Jenkins Academy of Applied Technology · DOT-101 · v1.0.0
DOT Drug and Alcohol Compliance — FMCSA — scope and source crosswalk
Course developed by Todd Jerome Jenkins, MS, CSP.
| Course | Lesson | Primary basis | Decision or workplace evidence |
|---|---|---|---|
| DOT-101 | Determining FMCSA testing coverage | 49 CFR 382.103 and 382.107 | Explain coverage using actual vehicle, license, operation and duty facts. |
| DOT-101 | Assigning responsibilities and driver education | 49 CFR 40.3,40.15,382.601 and 382.603 | Distinguish employer, DER, service agent, MRO, SAP, driver and trained-supervisor responsibilities. |
| DOT-101 | Understanding prohibitions and getting help | 49 CFR 382.201–382.215,382.121 and 382.505; DOT marijuana and CBD notices | Apply alcohol distinctions, medication safeguards and the employer’s actual help routes. |
| DOT-101 | Checking readiness before the first assignment | 49 CFR 382.301,382.413,382.701 and 40.25 | Keep pre-employment test, full query, history and licensing decisions separate. |
| DOT-101 | Maintaining a valid random program | 49 CFR 382.305; ODAPC 2026 Random Testing Rates | Explain valid selection, timely notification and current annual rates. |
| DOT-101 | Making post-accident testing decisions | 49 CFR 382.303 and 382.209 | Separate qualifying facts, citation windows, prompt testing and stop-attempt deadlines. |
| DOT-101 | Recognizing and escalating a possible impairment concern | 49 CFR 382.307 and 382.603 | Protect people, report facts and refer the testing determination to a properly trained official. |
| DOT-101 | Protecting test integrity and employee rights | 49 CFR 40.13,40.191,40.193,40.261,40.171 and 40.3; ODAPC laboratory list | Preserve the authorized testing process, factual refusal review and MRO-administered rights. |
| DOT-101 | Using Clearinghouse queries and reporting correctly | 49 CFR 382.701,382.703,382.705; Clearinghouse query-notification guidance | Distinguish query types, consent routes,24-hour follow-up and role-specific reporting. |
| DOT-101 | Managing removal, referral and return to duty | 49 CFR 382.501,382.503,40.285,40.287,40.305 and 40.307 | Preserve removal and the complete SAP, testing, follow-up and licensing pathway. |
| DOT-101 | Keeping confidential and retrievable program records | 49 CFR 382.401,382.405,382.701;49 CFR 40 subpartP | Select record-specific retention, access and secure retrieval controls. |
| DOT-101 | Connecting knowledge to the employer’s actual program | 49 CFR 382.601; employer implementation exercise | Identify missing real-world arrangements and keep the knowledge completion within its stated scope. |
Official sources
- 49 CFR 382.103
- 49 CFR 382.107
- 49 CFR 382.121
- 49 CFR 382.201
- 49 CFR 382.207
- 49 CFR 382.209
- 49 CFR 382.213
- 49 CFR 382.301
- 49 CFR 382.303
- 49 CFR 382.305
- 49 CFR 382.307
- 49 CFR 382.401
- 49 CFR 382.405
- 49 CFR 382.413
- 49 CFR 382.501
- 49 CFR 382.503
- 49 CFR 382.505
- 49 CFR 382.601
- 49 CFR 382.603
- 49 CFR 382.701
- 49 CFR 382.703
- 49 CFR 382.705
- 49 CFR 40.3
- 49 CFR 40.13
- 49 CFR 40.15
- 49 CFR 40.171
- 49 CFR 40.191
- 49 CFR 40.193
- 49 CFR 40.261
- 49 CFR 40.285
- 49 CFR 40.287
- 49 CFR 40.305
- 49 CFR 40.307
- 2026 DOT random testing rates
- FMCSA driver and supervisor training responsibilities
- Clearinghouse queries and consent
- Clearinghouse change notifications
- Current oral-fluid laboratory and device availability
- DOT marijuana notice
- DOT CBD notice
Source review: October 24, 2026. Federal FMCSA baseline; verify actual agency, operation, employer and current requirements. DOT-101 does not satisfy the separate section382.603 supervisor60+60-minute training. Guidance and Academy assessment rules are distinguished from statutory duties.